ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at Passage BIO, Inc. (PASG) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 26, 2025, ORBIMED ADVISORS LLC's relationship to Passage BIO, Inc. (PASG) is TenPercentOwner, and currently has 6,066,343 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PASG insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions of PASG Common Stock

ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at PASG

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 27, 2025	Sell -- (Common Stock)	213257	0.33	6066343
Jun 26, 2025	Sell -- (Common Stock)	138800	0.33	6279600
Jun 25, 2025	Sell -- (Common Stock)	231600	0.35	6418400
Apr 25, 2025	Sell -- (Common Stock)	68195	0.32	6650000
Apr 24, 2025	Sell -- (Common Stock)	89328	0.34	6718195
Apr 23, 2025	Sell -- (Common Stock)	78049	0.34	6807523
Jan 15, 2025	Sell -- (Common Stock)	79024	0.6	7034626
Jan 14, 2025	Sell -- (Common Stock)	17986	0.64	7113650
Jan 11, 2025	Sell -- (Common Stock)	126209	0.66	7131636
Dec 12, 2024	Sell -- (Common Stock)	80	0.8	7635190
Dec 11, 2024	Sell -- (Common Stock)	8015	0.8	7635270
Dec 10, 2024	Sell -- (Common Stock)	54181	0.84	7643285
Sep 20, 2024	Sell -- (Common Stock)	39300	0.71	7794569
Jun 29, 2023	P -- (Common Stock)	575195	0.84	8034000
Jun 28, 2023	P -- (Common Stock)	617382	0.84	7458805